Prognostic Indicators for H3K27M-Mutant Diffuse Midline Glioma: A Population-Based Retrospective Surveillance, Epidemiology, and End Results Database Analysis

GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas

Robbie G. Majzner, Sneha Ramakrishna, Kristen W. Yeom et al. · Nature · 2022 · 782 citations · Full text

Medicine, Immunology, Oncology +13

Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas

Christopher Mount, Robbie G. Majzner, Shree Sundaresh et al. · Nature Medicine · 2018 · 493 citations · Full text

Medicine, Cancer Biology, Oncology +10

Characteristics of H3 K27M-mutant gliomas in adults

David Meyronet, Maud Esteban-Mader, Charlotte Bonnet et al. · Neuro-Oncology · 2016 · 296 citations · Full text

Medicine, Molecular Genetics, Oncology +17

The landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and location

Ilon Liu, Li Jiang, Erik Samuelsson et al. · Nature Genetics · 2022 · 193 citations · Full text

Medicine, Cell Biology, Oncology +17

H3 K27M–mutant diffuse midline gliomas in different anatomical locations

Leiming Wang, Zhuo Li, Ming Zhang et al. · Human Pathology · 2018 · 173 citations

Medicine, Oncology, Pathology +10